Plenary Session 1: POTENTIALLY MALIGNANT DISORDERS (PMD): NEW CONCEPTS AND FUTURE PROSPECTS IN DIAGNOSIS AND MANAGEMENT

Plenary Session 1a

• INTRODUCTION: TERMINOLOGY AND CLASSIFICATION
• AN UPDATE ON EPIDEMIOLOGY OF PMD
• ETIOLOGY AND RISK FACTORS OF PMD
• THE ROLE OF HPV VIRUS IN PMD
• EARLY ORAL CANCER DIAGNOSIS : SCREENING TESTS AND DETECTION DEVICES

Plenary Session 1b

• CLINICAL CHARACTERISTICS OF PDM AND THEIR PROGNOSTIC SIGNIFICANCE
• HISTOPATHOLOGIC ASPECTS OF PMD AND THEIR PROGNOSTIC SIGNIFICANCE
• MOLECULAR BIOMARKERS: THE PRESENT AND THE FUTURE
• CHEMOPREVENTION:CURRENT STATUS AND FUTURE DIRECTIONS
• MANAGEMENT OF PMD: A CHALLENGING TASK
  

Plenary Session 2: NEW THERAPEUTIC MODALITIES IN ORAL MEDICINE

Plenary Session 2a

• NEW LOCALLY ADMINISTERED DRUGS FOR ORAL DISEASES
• IMMUNOSUPPRESSIVES/ IMMUNOMODULATORS IN ORAL MEDICINE
• BIOLOGICAL AGENTS: A NOVEL THERAPY FOR IMMUNE-MEDIATED ORAL DISEASES
• EVIDENCE-BASED THERAPY OF ORAL MUCOSAL DISEASES

Plenary Session 2b

• NEW DRUGS FOR THE MANAGEMENT OF NEUROPATHIC PAIN IN THE OROFACIAL REGION
• NEW DRUGS FOR THE MANAGEMENT OF ORAL INFECTIONS
• ADVERSE DRUG REACTIONS: WHAT IS NEW?
• NEW DRUGS OTHER THAN BISPHOSPHONATES AND OSTEONECROSIS OF THE JAWS
• LASERS IN ORAL MEDICINE: NOVEL APPLICATIONS